• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统医学与现代科学相遇:常山酮在对抗自身免疫性疾病中的作用。

Traditional medicine meets modern science: Halofuginone's role in combating autoimmune diseases.

作者信息

Zhu Juan, Liu Shiyao, Liu Peipei, Zhai Kefeng, Liu Hao

机构信息

School of Pharmacy, Bengbu Medical University, No.2600, Donghai Avenue, Bengbu, 233030, Anhui, China.

Anhui Engineering Technology Research Center of Biochemical Pharmaceutical, Bengbu Medical University, Bengbu, 233030, Anhui, China.

出版信息

J Nat Med. 2025 Jun 30. doi: 10.1007/s11418-025-01927-1.

DOI:10.1007/s11418-025-01927-1
PMID:40586966
Abstract

Dichroa febrifuga Lour., a traditional Chinese medicinal herb historically used for malaria treatment, contains the active compound Febrifugine. Through structural modification, Halofuginone was semi-synthesized, retaining antimalarial activity with reduced toxicity. Recent studies reveal Halofuginone's broad biologic activities, including significant therapeutic potential in autoimmune diseases. By modulating abnormal immune responses, suppressing inflammation, and exerting antifibrotic effects, Halofuginone alleviates symptoms and prevents tissue damage in these conditions. This review comprehensively summarizes advances in Halofuginone research for autoimmune diseases and discusses key challenges in this field.

摘要

常山,一种历史上用于治疗疟疾的传统中草药,含有活性化合物常山碱。通过结构修饰,半合成了卤夫酮,其保留了抗疟活性且毒性降低。最近的研究揭示了卤夫酮具有广泛的生物学活性,包括在自身免疫性疾病中具有显著的治疗潜力。通过调节异常免疫反应、抑制炎症以及发挥抗纤维化作用,卤夫酮可缓解这些疾病的症状并防止组织损伤。本综述全面总结了卤夫酮在自身免疫性疾病研究方面的进展,并讨论了该领域的关键挑战。

相似文献

1
Traditional medicine meets modern science: Halofuginone's role in combating autoimmune diseases.传统医学与现代科学相遇:常山酮在对抗自身免疫性疾病中的作用。
J Nat Med. 2025 Jun 30. doi: 10.1007/s11418-025-01927-1.
2
Prospects of halofuginone as an antiprotozoal drug scaffold.卤夫酮作为抗原生动物药物支架的前景。
Drug Discov Today. 2022 Sep;27(9):2586-2592. doi: 10.1016/j.drudis.2022.05.020. Epub 2022 May 27.
3
The chemistry and biology of febrifugine and halofuginone.常山碱和卤夫酮的化学与生物学
Bioorg Med Chem. 2014 Apr 1;22(7):1993-2004. doi: 10.1016/j.bmc.2014.02.040. Epub 2014 Mar 1.
4
Halofuginone - the multifaceted molecule.常山酮——具有多种功能的分子。
Molecules. 2015 Jan 5;20(1):573-94. doi: 10.3390/molecules20010573.
5
ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase.三磷酸腺苷定向捕获人类 tRNA 合成酶上的生物活性草药药物。
Nature. 2013 Feb 7;494(7435):121-4. doi: 10.1038/nature11774. Epub 2012 Dec 23.
6
[Advances in studies on autoimmune diseases treated by halofuginone].
Zhongguo Zhong Yao Za Zhi. 2017 Jun;42(11):2042-2045. doi: 10.19540/j.cnki.cjcmm.20170224.006.
7
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase.哈尔伏革酮和其他菲布罗嗪衍生物抑制脯氨酰-tRNA 合成酶。
Nat Chem Biol. 2012 Feb 12;8(3):311-7. doi: 10.1038/nchembio.790.
8
Hydroxy group requirement for halofuginone-dependent inhibition of muscle fibrosis and improvement of histopathology in the mdx mouse model for Duchenne muscular dystrophy.羟基基团要求对卤夫酮依赖性抑制肌肉纤维化和改善 Duchenne 肌营养不良症 mdx 小鼠模型的组织病理学的作用。
Histol Histopathol. 2019 Jul;34(7):791-801. doi: 10.14670/HH-18-083. Epub 2019 Jan 10.
9
Structure of Prolyl-tRNA Synthetase-Halofuginone Complex Provides Basis for Development of Drugs against Malaria and Toxoplasmosis.脯氨酰-tRNA 合成酶-卤泛菌素复合物的结构为开发抗疟疾和弓形体病药物提供了依据。
Structure. 2015 May 5;23(5):819-829. doi: 10.1016/j.str.2015.02.011. Epub 2015 Mar 26.
10
The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.疟原虫的细胞质脯氨酰-tRNA合成酶是 febrifugine 及其类似物的双阶段靶点。
Sci Transl Med. 2015 May 20;7(288):288ra77. doi: 10.1126/scitranslmed.aaa3575.

本文引用的文献

1
The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.临床抗寄生虫药物卤夫酮通过升高生长分化因子15(GDF15)和成纤维细胞生长因子21(FGF21)来促进体重减轻。
Sci Adv. 2025 Mar 28;11(13):eadt3142. doi: 10.1126/sciadv.adt3142. Epub 2025 Mar 26.
2
Experimental study on the inhibitory effect of Halofuginone on NSCLC.常山酮对非小细胞肺癌抑制作用的实验研究
Eur J Pharmacol. 2025 Feb 5;988:177221. doi: 10.1016/j.ejphar.2024.177221. Epub 2024 Dec 20.
3
Dual-targeted halofuginone hydrobromide nanocomplexes for promotion of macrophage repolarization and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes in adjuvant-induced arthritis in rats.
双靶点氢溴酸常山酮纳米复合物促进佐剂诱导的大鼠关节炎中巨噬细胞极化及类风湿关节炎成纤维样滑膜细胞凋亡的研究
J Pharm Anal. 2024 Nov;14(11):100981. doi: 10.1016/j.jpha.2024.100981. Epub 2024 Apr 22.
4
Integrated stress response activator halofuginone protects mice from diabetes-like phenotypes.整合应激反应激活剂卤泛群可保护小鼠免于出现类似糖尿病的表型。
J Cell Biol. 2024 Oct 7;223(10). doi: 10.1083/jcb.202405175. Epub 2024 Aug 16.
5
Inhibition of IL-17 signaling in macrophages underlies the anti-arthritic effects of halofuginone hydrobromide: Network pharmacology, molecular docking, and experimental validation.在巨噬细胞中抑制白介素-17 信号通路是卤夫酮氢溴酸盐抗关节炎作用的基础:网络药理学、分子对接和实验验证。
BMC Complement Med Ther. 2024 Feb 27;24(1):105. doi: 10.1186/s12906-024-04397-2.
6
Halofuginone for non-hospitalized adult patients with COVID-19 a multicenter, randomized placebo-controlled phase 2 trial. The HALOS trial.羟基脲治疗非住院成人 COVID-19 患者的多中心、随机、安慰剂对照 2 期试验。HALOS 试验。
PLoS One. 2024 Feb 23;19(2):e0299197. doi: 10.1371/journal.pone.0299197. eCollection 2024.
7
Assessment of the broad-spectrum host targeting antiviral efficacy of halofuginone hydrobromide in human airway, intestinal and brain organotypic models.在人气道、肠道和脑器官型模型中评估氢溴酸常山酮的广谱宿主靶向抗病毒疗效。
Antiviral Res. 2024 Feb;222:105798. doi: 10.1016/j.antiviral.2024.105798. Epub 2024 Jan 6.
8
Downregulation of nutrition sensor GCN2 in macrophages contributes to poor wound healing in diabetes.营养传感器 GCN2 在巨噬细胞中的下调导致糖尿病患者伤口愈合不良。
Cell Rep. 2024 Jan 23;43(1):113658. doi: 10.1016/j.celrep.2023.113658. Epub 2024 Jan 3.
9
SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.SLAMF3 促进 Th17 分化,依那西普通过 JAK1/STAT3 通路逆转原发性干燥综合征中的 Th17 分化。
Int Immunopharmacol. 2024 Jan 5;126:111282. doi: 10.1016/j.intimp.2023.111282. Epub 2023 Dec 6.
10
Pharmacologic activation of a compensatory integrated stress response kinase promotes mitochondrial remodeling in PERK-deficient cells.药物激活代偿性综合应激反应激酶可促进 PERK 缺陷细胞中线粒体重构。
Cell Chem Biol. 2023 Dec 21;30(12):1571-1584.e5. doi: 10.1016/j.chembiol.2023.10.006. Epub 2023 Nov 2.